English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Feb 23, 2026

Norwegian study explores challenges of funding high-cost drugs for rare diseases

Patient Daily | Feb 23, 2026

Study links insufficient sleep to higher risk of heart rhythm disorder

Patient Daily | Feb 23, 2026

Gut microbiome linked to varied responses for obesity and diabetes drugs

Patient Daily | Feb 23, 2026

Study links prenatal infection with higher adult alcohol misuse risk; antioxidants may help

Patient Daily | Feb 23, 2026

Study finds low COVID-19 and flu vaccination rates among pregnant women in Norway

Patient Daily | Feb 23, 2026

AI-driven DeepRare system shows promise for faster rare disease diagnosis

Patient Daily | Feb 23, 2026

Study links infant sensory sensitivity with reduced quality of deep sleep

Patient Daily | Feb 23, 2026

Gut microbiome analysis may help identify severe insulin resistance in type 2 diabetes

Trending

+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'

+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'

+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'

+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'

  • « First
  • «
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily